Table 2 TFRC expression and clinicopathological characteristics of patients with CRC
Characteristics | TFRC low experssion | TFRC high experssion | P | ||
|---|---|---|---|---|---|
N | % | N | % | ||
Gender | |||||
Male | 11 | 22.0 | 11 | 22.0 | > 0.9999 |
Female | 14 | 28.0 | 14 | 28.0 | |
Age(years) | |||||
< 56 | 13 | 26.0 | 12 | 24.0 | 0.7773 |
> 56 | 12 | 24.0 | 13 | 26.0 | |
Tumor size | |||||
T1 or T2 | 9 | 45.0 | 3 | 6.0 | 0.0469* |
T3 or T4 | 16 | 32.0 | 22 | 44.0 | |
Lymph node | |||||
N0 | 21 | 42.0 | 13 | 26.0 | 0.0502 |
N1 | 3 | 6.0 | 10 | 20.0 | |
N2 | 1 | 2.0 | 2 | 4.0 | |
Grade | |||||
1 | 3 | 6.0 | 3 | 6.0 | 0.3080 |
2 | 17 | 34.0 | 17 | 34.0 | |
2–3 | 4 | 8.0 | 1 | 2.0 | |
3 | 1 | 2.0 | 4 | 8.0 | |
Stage | |||||
I | 9 | 18.0 | 1 | 2.0 | 0.0055* |
II | 12 | 24.0 | 12 | 24.0 | |
III-IV | 4 | 8.0 | 12 | 24.0 | |